Pharmagreen Biotech Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHBI research report →
Companywww.pharmagreen.ca
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
- CEO
- Peter Wojcik
- IPO
- 2018
- HQ
- Coquitlam, BC, CA
Price Chart
Valuation
- Market Cap
- $622.21K
- P/E
- -1.07
- P/S
- 0.18
- P/B
- -0.06
- EV/EBITDA
- -1.60
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -0.02%
- Op Margin
- -37.46%
- Net Margin
- -16.27%
- ROE
- 13.33%
- ROIC
- 14.12%
Growth & Income
- Revenue
- $3.41K · 13.74%
- Net Income
- $-1,004,000 · -76.45%
- EPS
- $-0.00 · -25.00%
- Op Income
- $-248,000
- FCF YoY
- 61.96%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.87
- Avg Volume
- 2.47M
Get TickerSpark's AI analysis on PHBI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PHBI Coverage
We haven't published any research on PHBI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHBI Report →